Ekaterina Legchenko

7.4k total citations
20 papers, 737 citations indexed

About

Ekaterina Legchenko is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ekaterina Legchenko has authored 20 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Ekaterina Legchenko's work include Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Cardiovascular Function and Risk Factors (4 papers). Ekaterina Legchenko is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Cardiovascular Function and Risk Factors (4 papers). Ekaterina Legchenko collaborates with scholars based in Germany, United States and United Kingdom. Ekaterina Legchenko's co-authors include Georg Hansmann, Philippe Chouvarine, Paul Borchert, Danny Jonigk, Laurent Calvier, Miklós Mózes, Nadine Hoffmann, Martin Meier, Lavinia Maegel and S. Alex Mitsialis and has published in prestigious journals such as Nature Communications, Cell Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Ekaterina Legchenko

19 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ekaterina Legchenko Germany 10 357 307 230 124 110 20 737
El Houari Laghmani Netherlands 19 393 1.1× 575 1.9× 120 0.5× 161 1.3× 227 2.1× 30 1.1k
Daigo Sawaki Japan 18 261 0.7× 411 1.3× 429 1.9× 91 0.7× 170 1.5× 43 1.1k
Nana Burns United States 16 769 2.2× 375 1.2× 315 1.4× 143 1.2× 136 1.2× 26 1.2k
Todd R. Horn United States 9 239 0.7× 402 1.3× 246 1.1× 92 0.7× 57 0.5× 12 759
Masakuni Kido Japan 14 409 1.1× 480 1.6× 447 1.9× 195 1.6× 130 1.2× 24 1.2k
Daile Jia China 14 145 0.4× 348 1.1× 293 1.3× 108 0.9× 190 1.7× 19 853
Sarah L. Trinder United Kingdom 8 305 0.9× 221 0.7× 149 0.6× 40 0.3× 69 0.6× 13 577
Cheng Liu China 18 404 1.1× 353 1.1× 85 0.4× 169 1.4× 224 2.0× 93 919
Janet K. Lighthouse United States 13 278 0.8× 465 1.5× 348 1.5× 195 1.6× 200 1.8× 17 920
Mar Orriols Spain 14 241 0.7× 285 0.9× 139 0.6× 82 0.7× 95 0.9× 20 635

Countries citing papers authored by Ekaterina Legchenko

Since Specialization
Citations

This map shows the geographic impact of Ekaterina Legchenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekaterina Legchenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekaterina Legchenko more than expected).

Fields of papers citing papers by Ekaterina Legchenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekaterina Legchenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekaterina Legchenko. The network helps show where Ekaterina Legchenko may publish in the future.

Co-authorship network of co-authors of Ekaterina Legchenko

This figure shows the co-authorship network connecting the top 25 collaborators of Ekaterina Legchenko. A scholar is included among the top collaborators of Ekaterina Legchenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekaterina Legchenko. Ekaterina Legchenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legchenko, Ekaterina, Philippe Chouvarine, Fatimunnisa Qadri, et al.. (2025). Inhalation of the Novel Tryptophan Hydroxylase 1 Inhibitor TPT-004 Alleviates Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 73(2). 288–298.
2.
Liu, Bin, Ekaterina Legchenko, James A. West, et al.. (2024). ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport. Cardiovascular Research. 120(7). 756–768. 7 indexed citations
3.
Legchenko, Ekaterina, Philippe Chouvarine, Fatimunnisa Qadri, et al.. (2024). Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression. JACC Basic to Translational Science. 9(7). 890–902. 3 indexed citations
4.
Hansmann, Georg, Philippe Chouvarine, Martin Giera, et al.. (2022). Human umbilical cord mesenchymal stem cell-derived treatment of severe pulmonary arterial hypertension. Nature Cardiovascular Research. 1(6). 568–576. 13 indexed citations
5.
Legchenko, Ekaterina, Philippe Chouvarine, Richard Taubert, et al.. (2022). Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis. Frontiers in Cardiovascular Medicine. 9. 862330–862330. 6 indexed citations
6.
Legchenko, Ekaterina, Philippe Chouvarine, Ralf Lichtinghagen, et al.. (2021). Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. Frontiers in Cardiovascular Medicine. 8. 794549–794549. 4 indexed citations
7.
Chouvarine, Philippe, Hannes Sallmon, Brian D. Plouffe, et al.. (2021). Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 22(16). 8591–8591. 8 indexed citations
8.
Köhler, D., Tiago Granja, Julia Volz, et al.. (2020). Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb. Nature Communications. 11(1). 1315–1315. 52 indexed citations
9.
Klinke, Anna, Torben Schubert, Marion Müller, et al.. (2020). Emerging therapies for right ventricular dysfunction and failure. Cardiovascular Diagnosis and Therapy. 10(5). 1735–1767. 19 indexed citations
10.
Legchenko, Ekaterina, et al.. (2020). Protein truncating mutations in ATP13A3 promote pulmonary arterial hypertension in mice. 83–83. 3 indexed citations
11.
Calvier, Laurent, Philippe Chouvarine, Ekaterina Legchenko, et al.. (2019). Chronic TGF-β1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology. 61(1). 121–123. 16 indexed citations
12.
Kökény, Gábor, Laurent Calvier, Ekaterina Legchenko, et al.. (2019). PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis. Current Opinion in Nephrology & Hypertension. 29(2). 171–179. 45 indexed citations
13.
Chouvarine, Philippe, et al.. (2019). Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle. Journal of Molecular Medicine. 97(10). 1427–1438. 41 indexed citations
14.
Chouvarine, Philippe, et al.. (2019). Trans-Right–Ventricle and Transpulmonary MicroRNA Gradients in Human Pulmonary Arterial Hypertension*. Pediatric Critical Care Medicine. 21(4). 340–349. 22 indexed citations
15.
Legchenko, Ekaterina, Philippe Chouvarine, Paul Borchert, et al.. (2018). PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Science Translational Medicine. 10(438). 226 indexed citations
16.
Legchenko, Ekaterina, Philippe Chouvarine, Paul Borchert, et al.. (2018). P124The ppargamma agonist pioglitazone reverses pulmonary arterial hypertension (PAH) and prevents right heart failure through fatty acid oxidation (fao). Cardiovascular Research. 114(suppl_1). S32–S32. 1 indexed citations
17.
Calvier, Laurent, Philippe Chouvarine, Ekaterina Legchenko, et al.. (2017). PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism. Cell Metabolism. 25(5). 1118–1134.e7. 189 indexed citations
18.
Calvier, Laurent, Ekaterina Legchenko, Hannes Sallmon, et al.. (2016). Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension. Heart. 102(5). 390–396. 74 indexed citations
19.
Calvier, Laurent, Ekaterina Legchenko, Hannes Sallmon, et al.. (2016). Galectin-3 and Aldosterone as Potential Tandem Biomarkers in Pulmonary Arterial Hypertension. The Thoracic and Cardiovascular Surgeon. 64(S 02). 4 indexed citations
20.
Лавров, А. В., et al.. (2014). Analysis of Circulating Tumor Cells in Patients with Triple Negative Breast Cancer during Preoperative Chemotherapy. Bulletin of Experimental Biology and Medicine. 157(1). 159–161. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by El Houari Laghmani Breakdown of academic impact, for papers by Daigo Sawaki Breakdown of academic impact, for papers by Nana Burns Breakdown of academic impact, for papers by Todd R. Horn Breakdown of academic impact, for papers by Masakuni Kido Breakdown of academic impact, for papers by Daile Jia Breakdown of academic impact, for papers by Sarah L. Trinder Breakdown of academic impact, for papers by Cheng Liu Breakdown of academic impact, for papers by Janet K. Lighthouse Breakdown of academic impact, for papers by Mar Orriols
Rankless by CCL
2026